Triazolopyrimidine Nuclei: Privileged Scaffolds for Developing Antiviral Agents with a Proper Pharmacokinetic Profile.

Felicetti, Tommaso; Pismataro, Maria Chiara; Cecchetti, Violetta; Tabarrini, Oriana; Massari, Serena

Felicetti, Tommaso; Pismataro, Maria Chiara; Cecchetti, Violetta; Tabarrini, Oriana; Massari, Serena.

Afiliación

Felicetti T; Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy.
Pismataro MC; Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy.
Cecchetti V; Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy.
Tabarrini O; Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy.
Massari S; Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia,Italy.

Curr Med Chem ; 29(8): 1379-1407, 2022 Mar 04.

Article en En | MEDLINE | ID: mdl-34042030

Asunto(s)

Virosis; Virus; Antivirales/química; Antivirales/farmacología; Química Farmacéutica; Humanos; Relación Estructura-Actividad

Palabras clave

Triazolopyrimidines; antiviral drugs; medicinal chemistry; pharmacokinetic properties; small molecules; viral polymerase; viruses

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus / Virosis Límite: Humans Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google